- Investing Ideas
- South Korean Healthcare Undervalued based on future growth
South Korean Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
T&L
Market Cap: ₩491.5b
Engages in the manufacture and sale of medical and polymer material products in South Korea.
A340570
₩61,300.00
7D
7.4%
1Y
-11.5%
InBodyLtd
Market Cap: ₩388.1b
Provides body composition analysis solutions worldwide.
A041830
₩29,100.00
7D
-0.7%
1Y
23.8%
Value Added Technology
Market Cap: ₩346.1b
Manufactures and sells dental medical X-ray devices in Korea, Asia, Australia, Europe, North and South America, and the Middle East.
A043150
₩23,300.00
7D
0.9%
1Y
12.0%
Dentium
Market Cap: ₩336.8b
Manufactures and sells dental medical instrument worldwide.
A145720
₩54,500.00
7D
2.3%
1Y
-26.6%
Vieworks
Market Cap: ₩241.6b
Develops, manufactures, and sells imaging systems and solutions.
A100120
₩28,150.00
7D
0.7%
1Y
14.9%
Interojo
Market Cap: ₩234.0b
Manufactures and sells contact lenses in South Korea and internationally.
A119610
₩20,500.00
7D
4.1%
1Y
n/a
Meta Biomed
Market Cap: ₩117.8b
Engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa.
A059210
₩4,505.00
7D
1.9%
1Y
-5.0%